CPIG
IRWD icon

Chicago Partners Investment Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Chicago Partners Investment Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.4K Sell
11,972
-6,511
-35% -$25.1K ﹤0.01% 1519
2026
Q1 		$77.3K Buy
+18,483
New +$75.8K ﹤0.01% 1403

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Chicago Partners Investment Group's IRWD Position: Q2 2026 in Review

Chicago Partners Investment Group reduced its Ironwood Pharmaceuticals (IRWD) stake by 35% in Q2 2026, selling an estimated $25.1K and leaving 11,972 shares worth $45.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1519.

Chicago Partners Investment Group first reported a position in IRWD in Q1 2026 and has held it in 2 quarters since. The position peaked at $77.3K in Q1 2026. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Chicago Partners Investment Group held 11,972 shares of Ironwood Pharmaceuticals worth $45.4K as of Q2 2026.
  • Chicago Partners Investment Group sold 6,511 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $25.1K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Chicago Partners Investment Group's portfolio in Q2 2026, its #1519 holding.
  • Chicago Partners Investment Group first reported a position in Ironwood Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Chicago Partners Investment Group's Ironwood Pharmaceuticals position peaked at $77.3K in Q1 2026.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.